Yao, Feiqun, and Zhewei Shi. “MiR-16 Is Promising to Be a Therapy Target to Alleviate Atherosclerosis”. Diagnostics and Therapeutics 2, no. 1 (January 16, 2023): 13–15. Accessed December 25, 2024. https://ojs.luminescience.cn/DT/article/view/161.